Clinical Trials Browser

Phase 1/2 × Breast Neoplasms, Male × Granulocyte-Macrophage Colony-Stimulating Factor × Clear all

NCT01355393 2020-02-10

Vaccine Therapy in Combination With Rintatolimod and/or Sargramostim in Treating Patients With Stage II-IV HER2-Positive Breast Cancer

Phase 1/2 Completed

Breast Neoplasms, Breast Neoplasms, Male

NCT00791037 2017-05-25

Vaccine Therapy in Treating Patients With Stage IV Breast Cancer

Phase 1/2 Completed

23 enrolled 9 charts

Breast Neoplasms, Breast Neoplasms, Male